+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
Catalepsy Treatment Market Report 2026 - Product Thumbnail Image

Catalepsy Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hormonal Supplements Market - Global Forecast 2025-2030 - Product Thumbnail Image

Hormonal Supplements Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
From
Cell & Gene Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cell & Gene Therapy Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 182 Pages
  • Global
From
From
From
From
From
From
Base Editing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Base Editing Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Proliferative Diabetic Retinopathy (PDR) Market Report 2026 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drug Discovery Market Report 2026 - Product Thumbnail Image

Drug Discovery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Orphan Drugs Market Report 2026 - Product Thumbnail Image

Orphan Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Bi-Specific MAbS Market Report 2026 - Product Thumbnail Image

Bi-Specific MAbS Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator